Forsyth - Discovery + Innovation + Wellness

Sign up for a study

Sign up for news

Donate online



Home > About Forsyth >

Board of Directors

The Forsyth Institute Board of Directors

Chairman of the Board

Peter Nessen
President
Corporate Realty Investment Company, L.L.C.

Donald Barr
President and Chief Executive Officer
Barr & Barr, Inc.

Stanley M. Bergman
Chairman, CEO and President
Henry Schein, Inc.

Elyse Cherry
Chief Executive Officer
Boston Community Capital
President, Boston Coummunity Venture Fund

David Elllis
Past President
Museum of Science Boston

Dr. John Ficarelli
Pediatric Dental Associates of Brookline, P.C.

Dr. Steven Freedman
Chief of the Division of Translational Research and Director of Clinical Research Affairs at Beth Israel Deaconess Medical Center

Helena Hartnett
Managing Director, The Jeremiah Group, LLC

Rosalee Hermens
Vice President and CIO
True Value Company

Janet Kelly
Principal
Boston Marketing Advisors

Steve Phillips
President
Phillips Design Group

Walter Pressey
Board of Advisors at Patina Solutions
Member, Finance Committee at Children's Hospital Boston
Chairman of the Board at Program in Cellular and Molecular Medicine/Immune Disease Institute

John Plukas
Co-Founder Wainwright Capital Management LLP

Nancy J. Rosenzweig
Social Enterprise CEO and Strategist

Anthony R. Volpe, D.D.S.
Vice President of Clinical Dental Research
Colgate-Palmolive Company

 

 

The Forsyth Institute 245 First Street,Cambridge MA, 02142
V: 617.262.5200 F: 617.262.4021